Showing results (61-70 of 221) with videos related to

Sort By:
Pageof 23
Brain Sciences|February 25, 2022
Relationships between Diffusion Tensor Imaging and Resting State Functional Connectivity in Patients with Schizophrenia and Healthy Controls: A Preliminary StudyMatthew J Hoptman, Umit Tural, Kelvin O Lim, et al.
The Journal of Clinical Psychiatry|June 1, 2022
Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients With Major Depressive Disorder: A Phase 3 Randomized Clinical Trial (GEMINI)Dan V Iosifescu, Amanda Jones, Cedric O'Gorman, et al.
Journal of Psychopharmacology (Oxford, England)|September 1, 2017
A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapyCynthia Richards, Dan V Iosifescu, Rajnish Mago, et al.
Neuropsychiatric Disease and Treatment|September 21, 2011
Retrospective chart review of a referenced EEG database in assisting medication selection for treatment of depression in patients with eating disordersJames M Greenblatt, Craig Sussman, Mariko Jameson, et al.
Depression and Anxiety|September 16, 2004
Panic Disorder Severity Scale: reliability and validity of the Turkish versionE Serap Monkul, Umit Tural, Elif Onur, et al.
Annals of the New York Academy of Sciences|February 5, 2015
The promise of ketamine for treatment-resistant depression: current evidence and future directionsKaitlin E DeWilde, Cara F Levitch, James W Murrough, et al.
The Journal of Clinical Psychiatry|January 7, 2011
A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depressionMaurizio Fava, Kendyl Schaefer, Holly Huang, et al.
The Australian and New Zealand Journal of Psychiatry|June 20, 2012
Mitochondrial modulators for bipolar disorder: a pathophysiologically informed paradigm for new drug developmentAndrew A Nierenberg, Christine Kansky, Brian P Brennan, et al.
Psychosomatics|May 5, 2004
Effect of medical comorbidity on response to fluoxetine augmentation or dose increase in outpatients with treatment-resistant depressionRoy H Perlis, Dan V Iosifescu, Jonathan Alpert, et al.
Psychiatry Research|March 16, 2007
Autonomic reactivity to induced emotion as potential predictor of response to antidepressant treatmentRenerio Fraguas, Carl Marci, Maurizio Fava, et al.
Pageof 23